Literature DB >> 9445329

Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial.

O M Rønning1, B Guldvog.   

Abstract

BACKGROUND AND
PURPOSE: The long-term effect on survival of treatment in stroke units is still under debate. The hypothesis that a stroke unit with short length of stay increases 1-year and 18-month survival rates was tested in this study.
METHODS: A quasi-randomized, controlled study was undertaken among 802 patients > or =60 years old admitted to the Central Hospital of Akershus in Norway with a diagnosis of stroke between January 1, 1993, and February 1, 1995. All patients with onset of symptoms <24 hours before admittance were included and enrolled and were followed until death or to the end of the observation 18 months after stroke. Patients were allocated to a stroke unit (n=364) or a general medical ward (n=438).
RESULTS: Case fatality within the first 10 days was 8.2% among patients in the stroke unit and 15.1% among patients in the general medical ward (P=.0019). One-year survival among patients treated in the stroke unit was 70.6% and in the general medical wards 64.6% (P=.026); 18-month survival rates were 65.1% and 58.0%, respectively (P=.021). Among patients with cerebral hemorrhage, 10-day case fatality was 24.5% and 51.6% (P=.004) in favor of the stroke unit.
CONCLUSIONS: Stroke units increase survival rates among stroke patients compared with general medical wards. The effect on survival occurs early after the stroke and sustains during at least 18 months of observation.

Entities:  

Mesh:

Year:  1998        PMID: 9445329     DOI: 10.1161/01.str.29.1.58

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

Review 1.  Medical therapy for acute ischemic stroke.

Authors:  L B Goldstein
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

2.  Is Canada falling behind international standards for stroke care?

Authors:  A M Hakim; F Silver; C Hodgson
Journal:  CMAJ       Date:  1998-09-22       Impact factor: 8.262

3.  The benefit of an acute stroke unit in patients with intracranial haemorrhage: a controlled trial.

Authors:  O M Rønning; B Guldvog; K Stavem
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

Review 4.  Thrombolysis, stroke units and other strategies for reducing acute stroke costs.

Authors:  T H Wein; S L Hickenbottom; A V Alexandrov
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

5.  [Management of patients with intracerebral hemorrhages on Austrian Stroke Units: results of the GOG-BIQG Austrian Stroke Units Registry 2003-2007].

Authors:  Raoul Eckhardt; Stefan Schnabl; Michael Brainin
Journal:  Wien Med Wochenschr       Date:  2008

Review 6.  1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.

Authors:  S Meltzer; L Leiter; D Daneman; H C Gerstein; D Lau; S Ludwig; J F Yale; B Zinman; D Lillie
Journal:  CMAJ       Date:  1998       Impact factor: 8.262

7.  [Telemedicine stroke department network. Introduction of a telemedicine pilot project for integrated stroke management in South Bavaria and analysis of its efficiency].

Authors:  H J Audebert; M L J Wimmer; J Schenkel; K Ulm; P L Kolominsky-Rabas; U Bogdahn; M Horn; R L Haberl
Journal:  Nervenarzt       Date:  2004-02       Impact factor: 1.214

8.  Derivation and validation of a simple risk score for predicting 1-year mortality in stroke.

Authors:  O G Solberg; M Dahl; P Mowinckel; K Stavem
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

9.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

10.  Impact of implementing evidence-based acute stroke interventions on survival: the South London Stroke Register.

Authors:  Juliet Addo; Siobhan Crichton; Ajay Bhalla; Anthony G Rudd; Charles D A Wolfe; Christopher McKevitt
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.